Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 25.23
(0.6%)
CNY 25.23
(0.6%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 14 Billion CNY | 8.3% |
| 2022 | 12.86 Billion CNY | -14.38% |
| 2021 | 15.03 Billion CNY | 153.79% |
| 2020 | 5.92 Billion CNY | 33.04% |
| 2019 | 4.45 Billion CNY | 55.46% |
| 2018 | 2.86 Billion CNY | 171.54% |
| 2017 | 1.05 Billion CNY | 156.74% |
| 2016 | 410.72 Million CNY | -28.07% |
| 2015 | 570.97 Million CNY | 16.49% |
| 2014 | 490.14 Million CNY | 3.82% |
| 2013 | 472.12 Million CNY | 10.73% |
| 2012 | 426.36 Million CNY | 12.75% |
| 2011 | 378.15 Million CNY | -19.2% |
| 2010 | 468 Million CNY | 12.63% |
| 2009 | 415.54 Million CNY | 10.67% |
| 2008 | 375.48 Million CNY | 31.72% |
| 2007 | 285.05 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 1.33 Billion CNY | -28.44% |
| 2024 Q2 | 1.87 Billion CNY | -35.89% |
| 2024 Q1 | 2.91 Billion CNY | -4.68% |
| 2023 Q2 | 3.83 Billion CNY | 13.38% |
| 2023 Q3 | 3.87 Billion CNY | 1.03% |
| 2023 Q4 | 3.06 Billion CNY | -21.06% |
| 2023 FY | 13.93 Billion CNY | 8.3% |
| 2023 Q1 | 3.38 Billion CNY | -6.77% |
| 2022 Q2 | 3.16 Billion CNY | 6.24% |
| 2022 Q3 | 3.09 Billion CNY | -2.09% |
| 2022 Q4 | 3.63 Billion CNY | 17.27% |
| 2022 FY | 12.86 Billion CNY | -14.38% |
| 2022 Q1 | 2.97 Billion CNY | -8.12% |
| 2021 Q1 | 1.6 Billion CNY | 7.18% |
| 2021 Q3 | 4.11 Billion CNY | -32.29% |
| 2021 Q4 | 3.24 Billion CNY | -21.18% |
| 2021 FY | 15.03 Billion CNY | 153.79% |
| 2021 Q2 | 6.07 Billion CNY | 277.61% |
| 2020 Q3 | 1.73 Billion CNY | 1.05% |
| 2020 Q2 | 1.71 Billion CNY | 75.38% |
| 2020 Q1 | 977.07 Million CNY | -20.96% |
| 2020 FY | 5.92 Billion CNY | 33.04% |
| 2020 Q4 | 1.5 Billion CNY | -13.35% |
| 2019 Q4 | 1.23 Billion CNY | 8.36% |
| 2019 FY | 4.45 Billion CNY | 55.46% |
| 2019 Q3 | 1.14 Billion CNY | -1.63% |
| 2019 Q2 | 1.15 Billion CNY | 26.82% |
| 2019 Q1 | 914.57 Million CNY | 4.42% |
| 2018 Q2 | 765.77 Million CNY | 66.2% |
| 2018 Q3 | 760.95 Million CNY | -0.63% |
| 2018 FY | 2.86 Billion CNY | 171.54% |
| 2018 Q1 | 460.75 Million CNY | 21.92% |
| 2018 Q4 | 875.89 Million CNY | 15.1% |
| 2017 Q4 | 377.9 Million CNY | 42.13% |
| 2017 Q3 | 265.88 Million CNY | 2.86% |
| 2017 FY | 1.05 Billion CNY | 156.74% |
| 2017 Q1 | 152.21 Million CNY | -3.27% |
| 2017 Q2 | 258.49 Million CNY | 69.83% |
| 2016 FY | 410.72 Million CNY | -28.07% |
| 2016 Q4 | 157.36 Million CNY | 83.09% |
| 2016 Q3 | 85.94 Million CNY | 156.41% |
| 2016 Q2 | 33.51 Million CNY | -74.97% |
| 2016 Q1 | 133.89 Million CNY | -7.82% |
| 2015 Q3 | 153.34 Million CNY | -0.8% |
| 2015 Q4 | 145.24 Million CNY | -5.28% |
| 2015 FY | 570.97 Million CNY | 16.49% |
| 2015 Q1 | 117.79 Million CNY | -12.91% |
| 2015 Q2 | 154.58 Million CNY | 31.23% |
| 2014 Q3 | 120.41 Million CNY | -13.98% |
| 2014 FY | 490.14 Million CNY | 3.82% |
| 2014 Q1 | 94.47 Million CNY | -32.05% |
| 2014 Q2 | 139.99 Million CNY | 48.19% |
| 2014 Q4 | 135.25 Million CNY | 12.32% |
| 2013 Q3 | 95.92 Million CNY | -34.44% |
| 2013 FY | 472.12 Million CNY | 10.73% |
| 2013 Q1 | 90.85 Million CNY | -40.98% |
| 2013 Q2 | 146.31 Million CNY | 61.04% |
| 2013 Q4 | 139.02 Million CNY | 44.93% |
| 2012 Q1 | 70.73 Million CNY | -29.42% |
| 2012 FY | 426.36 Million CNY | 12.75% |
| 2012 Q2 | 101.83 Million CNY | 43.97% |
| 2012 Q3 | 99.85 Million CNY | -1.94% |
| 2012 Q4 | 153.94 Million CNY | 54.17% |
| 2011 Q4 | 100.21 Million CNY | 27.46% |
| 2011 Q3 | 78.62 Million CNY | -33.78% |
| 2011 Q2 | 118.73 Million CNY | 47.35% |
| 2011 Q1 | 80.57 Million CNY | -49.21% |
| 2011 FY | 378.15 Million CNY | -19.2% |
| 2010 Q3 | 80.96 Million CNY | -51.15% |
| 2010 Q2 | 165.75 Million CNY | 164.65% |
| 2010 Q1 | 62.63 Million CNY | -52.23% |
| 2010 FY | 468 Million CNY | 12.63% |
| 2010 Q4 | 158.64 Million CNY | 95.94% |
| 2009 Q4 | 131.1 Million CNY | 46.84% |
| 2009 Q3 | 89.28 Million CNY | 0.0% |
| 2009 FY | 415.54 Million CNY | 10.67% |
| 2008 FY | 375.48 Million CNY | 31.72% |
| 2007 FY | 285.05 Million CNY | 0.0% |